XIGDUO XR 1000 mg/1

Xigduo XR 1000 mg/1 combines dapagliflozin and metformin hydrochloride for extended-release blood sugar management. This oral medication supports glucose control in adults with type 2 diabetes.

Xigduo XR 1000 mg/1 is designed to help manage blood sugar levels in adults with type 2 diabetes. It combines two active ingredients, dapagliflozin and metformin hydrochloride, to support glucose control. This extended-release tablet is typically used as part of a broader diabetes management plan, which may include diet and exercise.

Common effects of Xigduo XR 1000 mg/1 may include symptoms such as nausea, diarrhea, or headache. Some individuals may also experience urinary tract infections or low blood sugar, especially when combined with other medications. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Xigduo XR 1000 mg/1 should be handled with care, particularly for those with kidney issues or a history of lactic acidosis. It is essential to follow the prescribed dosage and administration instructions. Always inform your healthcare provider about any existing medical conditions or other medications you are taking.

Xigduo XR 1000 mg/1 may interact with certain medications, including those that affect kidney function or blood sugar levels. Alcohol consumption should be avoided, as it can increase the risk of lactic acidosis. Always consult a healthcare provider before starting or stopping any medication.